In a mouse model of multiple myeloma, osteoclasts have been found to express CCR2-targeting chemokines, and an anti-CCR2 monoclonal antibody was able to block osteoclast chemoattractant activity for multiple myeloma cells (61). The gene discussed is CCR2; the disease is plasma cell myeloma.